Clinical Trials Directory

Trials / Completed

CompletedNCT05178446

GERD After Sleeve Gastrectomy

The New Onset of GERD After Sleeve Gastrectomy: a Systematic Review

Status
Completed
Phase
Study type
Observational
Enrollment
14,362 (actual)
Sponsor
University of Foggia · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The main adverse effect is gastroesophageal reflux disease (GERD), with concern on the development of Barrett's esophagus and esophageal adenocarcinoma in the long term. However, the relationship between SG and GERD is complex. The aim of this study is to systematically evaluate all published data existing in the literature to evaluate the effect of sleeve gastrectomy on GERD, esophagitis, BE in order to clarify the long-term clinical sequelae of this procedure. This systematic review was conducted in accordance with the guidelines for Preferred Reporting Items for Systematic Review and Meta-analyzes (PRISMA). Published studies that contained outcome data for primary sleeve gastrectomy associated with the primary and secondary outcomes listed below were included.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2021-03-01
Completion
2021-12-01
First posted
2022-01-05
Last updated
2022-01-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05178446. Inclusion in this directory is not an endorsement.

GERD After Sleeve Gastrectomy (NCT05178446) · Clinical Trials Directory